Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 20/20 | 0.71 |
| ▸ | KCNH2 | Q12809 | 13/20 | 0.71 |
| ▸ | SCN5A | Q14524 | 15/20 | 0.59 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.49 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.49 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3892332 | 0.83 | SCN9A (0.84) | SCN9AKCNH2SCN5AKCNQ2KCNA5 | |
| SCHEMBL4321010 | 0.83 | SCN9A (1.00) | SCN9AKCNH2SCN5AKCNQ2KCNA5 | |
| SCHEMBL4329746 | 0.81 | SCN9A (0.83) | SCN9AKCNH2SCN5AKCNQ2KCNA5 | |
| SCHEMBL4333389 | 0.79 | SCN9A (0.75) | SCN9AKCNH2SCN5AKCNQ2KCNA5 | |
| SCHEMBL4334843 | 0.78 | SCN9A (0.87) | SCN9AKCNH2SCN5AKCNQ2KCNA5 | |
| SCHEMBL4322464 | 0.77 | SCN9A (0.82) | SCN9AKCNH2SCN5AKCNQ2KCNA5 | |
| SCHEMBL4332779 | 0.77 | SCN9A (0.58) | SCN9AKCNH2SCN5A | |
| SCHEMBL13577793 | 0.75 | SCN9A (0.70) | SCN9AKCNH2SCN5A | |
| SCHEMBL3957356 | 0.74 | SCN9A (1.00) | SCN9AKCNH2SCN5AKCNQ2KCNA5 | |
| SCHEMBL4339063 | 0.73 | SCN9A (0.83) | SCN9AKCNH2SCN5AKCNQ2KCNA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009145719-A1 | ISOINDOLINE DERIVATIVES COMPRISING A CYANO GROUP AND THEIR USE IN THE TREATMENT OF PAIN DISORDERS | ASTRAZENECA AB (SE) | 2009-12-03 | — | — | WO | claimed |